🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 52886X107
- IPO
- 11/3/2023 · $11:00/share
Business: Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease are treated
Company Contact
- CEO
- R. Nolan Townsend
- CFO
- Louis Tamayo
- Headquarters
- 345 Park Avenue South, Floor 6, New York, NY 10010
- Phone
- 212-547-9879
- Investor Relations
- Carlo Tanzi · 212-547-9879 · ctanzi@kendallir.com